A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Extended Myositis Panel
Test Code39933
CPT Codes
**Restricted Client Code**
Includes
SSA-52 (Ro52)(ENA)Ab, IgG
SSA-60 (Ro60)(ENA)Ab, IgG
Smith/RNP (ENA) Ab, IgG
Jo-1 Ab, IgG
PL-12 Antibody
PL-7 Antibody
EJ Antibody
OJ Antibody
SRP Ab
Ku Antibody
PM/Scl 100 Antibody, IgG
Fibrillarin(U3 RNP)Ab,IgG
Mi-2 Antibody
P155/140 Antibody
TIF-1 gamma (155 kDa) Ab
SAE1 Ab
MDA5 (CADM-140) Ab
NXP2 Ab
SSA-60 (Ro60)(ENA)Ab, IgG
Smith/RNP (ENA) Ab, IgG
Jo-1 Ab, IgG
PL-12 Antibody
PL-7 Antibody
EJ Antibody
OJ Antibody
SRP Ab
Ku Antibody
PM/Scl 100 Antibody, IgG
Fibrillarin(U3 RNP)Ab,IgG
Mi-2 Antibody
P155/140 Antibody
TIF-1 gamma (155 kDa) Ab
SAE1 Ab
MDA5 (CADM-140) Ab
NXP2 Ab
Preferred Specimen
1 mL serum (x3)
Minimum Volume
0.5 mL aliquots (x3)
Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer three 1 mL serum aliquots to ARUP standard transport tubes.
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 14 days
Frozen: 1 month
Refrigerated: 14 days
Frozen: 1 month
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis • Grossly lipemic • Icteric • Heat-treated • Contaminated specimens
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay • Qualitative Immunoprecipitation • Semi-Quantitative Multiplex Bead Assay • Qualitative Immunoblot
FDA Status
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 7-18 days
Clinical Significance
May be useful for differential evaluation of polymyositis, dermatomyositis, necrotizing autoimmune myopathy, or overlap syndromes associated with connective tissue disease.